标普和纳斯达克内在价值 联系我们

Daxor Corporation DXR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
89/100
6/7 Pass
SharesGrow Intrinsic Value
$39.98
+326.2%
Analyst Price Target
$23.00
+145.2%

Daxor Corporation (DXR) 是一家上市公司 属于 医疗保健 板块,经营于 Medical - Instruments & Supplies 行业. 公司总部位于 Oak Ridge, TN, 美国. 现任CEO为 Michael Richard Feldschuh.

DXR 拥有 IPO日期为 1983-07-25, 37 名全职员工, 在 NASDAQ Capital Marke, 市值为 $47.26M.

关于 Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

📍 109 Meco Lane, Oak Ridge, TN 37830 📞 12123308500
公司详情
所属板块医疗保健
细分行业Medical - Instruments & Supplies
国家美国
交易所NASDAQ Capital Marke
货币USD
IPO日期1983-07-25
首席执行官Michael Richard Feldschuh
员工数37
交易信息
当前价格$9.38
市值$47.26M
52周区间7.1-14.76
Beta0.14
ETF
ADR
CUSIP239467103
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言